This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Clinical features

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Non-Hodgkin's lymphoma (NHL) is typically disseminated at presentation,

  • painless lymphadenopathy - seen in two-thirds of patients presents which is often generalised. (in contrast the lymphadenopathy of Hodgkin's disease is often localised to a single group of nodes) (1).
  • visceral lymphadenopathy is common, often resulting in heavy tumour burden but with few symptoms.
  • peripheral lymphadenopathy is typically seen in low grade lymphomas (1)

There is more extranodal involvement seen in non-Hodgkin's lymphoma and any organ can be the primary site of NHL

  • gastrointestinal tract is the most common site out of which stomach is the most frequently implicated part
  • NHL is the most common testicular tumour (usually aggressive B-cell tumours) in men older than 60 years (1).

B symptoms indicate an adverse prognosis. B symptoms are:

  • weight loss >10%
  • night sweats
  • pyrexia >38C

Non-Hodgkin's lymphoma may also present with anaemia, infections or purpura.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.